SAN DIEGO (AP) _ Neurocrine Biosciences Inc. (NBIX) on Monday reported a loss of $102.1 million in its first quarter. The San Diego-based company ...
News
- Neurocrine: 1Q Earnings Snapshot
- City Hall Is the Best Prep for the White House
As mayor of San Antonio, Castro pushed for global connections for his city's innovation, technology, and biomedical industries, and he even led a trade delegation to Israel to forge working agreements between the San Antonio ...
- What's in Zymeworks Inc. (ZYME) After Today's Significant Increase?
... the San Antonio Breast Cancer Symposium – Business Wire” published on December 08, 2018, Investorideas.com published: “BiotechIndustryStocks.com investing ideas for biotech stocks, biotechnology stocks news and investor ...
- Technology is reshaping the future of healthcare, from biotechs that use your body to fight disease ...
Tech and healthcare are converging. Just take the Apple Watch. The slim device can take your pulse, call for help if you fall, and of course track your ...
- A crop of new startups has popped up promising to make going to the doctor easier and cheaper. I ...
Subscribe to Dispensed, our weekly newsletter on pharma, biotech, and healthcare. The goal many seem to be getting at is making healthcare a more ...